Adoptive Cell Therapy in Hepatocellular Carcinoma: A Review of Clinical Trials

SIMPLE SUMMARY: Immunotherapy has become the standard frontline treatment for patients with advanced hepatocellular carcinoma (HCC). However, drug resistance is a major limitation and novel strategies are needed for better clinical outcomes. In this review, we discuss adoptive cell therapy (ACT) as...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozer, Muhammet, Goksu, Suleyman Yasin, Akagunduz, Baran, George, Andrew, Sahin, Ilyas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046758/
https://www.ncbi.nlm.nih.gov/pubmed/36980692
http://dx.doi.org/10.3390/cancers15061808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046758/
https://www.ncbi.nlm.nih.gov/pubmed/36980692
http://dx.doi.org/10.3390/cancers15061808

Ejemplares similares